EUVIMEDEUVIMED entdecken
Crossref

A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories

Yusuf Cem Kaplan

Türkiye Aile Hekimliği Dergisi · 2014

DOI: 10.15511/tahd.14.04195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Türkiye Aile Hekimliği Dergisi, 2014. Verfasst von Yusuf Cem Kaplan. Die Arbeit wurde bisher 11-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twenty nine years after the introduction of Pregnancy Risk Categories, U.S. Food and Drug Administration (FDA) concluded that categories were not successful at conveying the possible risks of drug use in pregnancy. FDA announced its second generation approach to labeling drugs for use in pregnancy and lactation with the publication of Proposed Rule for Pregnancy and Lactation Labeling for Human Prescription Drug and Biological Products on May 29, 2008. The proposed rule is designed as a narrative text containing elements such as fetal risk summary, clinical considerations and data. This manuscript aims to increase information and awareness of family practitioners on this subject.

Zitieren

APA

Kaplan, Y. C. (2014). A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories. Türkiye Aile Hekimliği Dergisi. https://doi.org/10.15511/tahd.14.04195

Vancouver

Kaplan YC. A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories. Türkiye Aile Hekimliği Dergisi. 2014. doi:10.15511/tahd.14.04195

BibTeX
@article{Kaplan2014,
  author = {Kaplan, Yusuf Cem},
  title = {A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories},
  journal = {Türkiye Aile Hekimliği Dergisi},
  year = {2014},
  doi = {10.15511/tahd.14.04195}
}
Kostenlos starten →